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Main results: Intraperitoneal implantation of purified 
beta-cells improved the diabetic state within 8-10 days. 
The metabolic parameters were stable within 4-5 weeks 
after islet transplantation in fifteen of twenty-one 
recipients (71.4%). Stimulation with PHA at 21 days 
post beta- cells grafts produced a marked increase in 3H- 
Thymidine incorporation in lamina propria and Peyer’s 
patches lymphoid T cells. 
Conclusions: (1) These results demonstrated normal- 
ization of metabolic and immunologic parameters 
in diabetic rats which received associated therapy 
(pancreatic beta-cells and E. coli vaccine) and (2) beta- 
cells stimulated the immune response to Escherichia coli 
vaccine. 
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Allogeneic stem cell transplantation from donors other 
than HLA-matched siblings results in a high risk of post- 
transplant infections because of the risk of graft-versus- 
host disease (GVHD) with an unmanipulated graft, or 
delayed immune reconstitution following T cell-depletion 
(TCD). We compared infectious outcomes in the first 
yr post-transplant (tx) in 28 consecutive recipients of 
stringently TCD blood hematopoeitic progenitor cell 
(HPC) grafts from haploidentical family donors (HD), 
and 28 consecutive recipients of unmanipulated grafts 
from matched or 1 Ag mismatched unrelated donors 
(URD). Included are pts (excluding CML-CPl) trans- 
planted at our center between 6198 and 12/01 after 
myeloablative conditioning. HD pts received pre-tx ATG, 
and no scheduled post-tx immunosuppression. URD pts 
received tacrolimus and methotrexate for GVHD 
prophylaxis. Median CD3-t cell dose/kg was 3.6 logs 
lower in the HD vs URD grafts (p<O.OOOl). Median age 
was 31y (21-56) for HD and 43y (18-51) for URD pts. 
15 HD and 17 URD pts were in relapse at time of 
transplant. Acute and/or chronic extensive GVHD 
occurred in 80% of evaluable URD pts vs 15% of HD 
pts (p<O.OOl). Bacteremias were the most common in- 
fections, occurring at similar frequencies in the two groups. 
Polymicrobial bacteremias occurred exclusively in URD 
patients (n=7; p=O.O09). Proven/probable invasive 
fungal infections (IFI) occurred in 23% of HD pts, and 
12% of URD pts (p =NS). Frequency and timing of 
CMV reactivation (by PCR), late CMV reactivation (>d 
loo), and CMV disease were similar in the two groups. 
EBV-associated PTLD was unique to HD pts (n=3), 
and drug-resistant HSV disease was also more common 
after HD tx. Infection related deaths (censored at 1 yr) 
in HD pts included bacterial sepsis (3),Aspergillosis (3) 
parainfluenza pneumonia (2) PCP (1) other pneumonia 
(l), amebic encephalitis (1) toxoplasmosis (1) EBV- 
PTLD (l), and acalculous cholecystitis (1). Infectious 
deaths in URD pts resulted from IF1 (3) bacterial sepsis 
(2), CMV pneumonia (1) aspiration pneumonia (1) and 
acalculous cholecystitis (1). 
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Infections are the most common cause of death in these 
pts. The trend toward higher risk of infectious death 
following TCD HD vs unmanipulated URD transplants 
was not statistically significant, although the spectrum of 
infections was different. Strategies aimed at enhancing 
immune reconstitution without stimulating GVHD are 
needed to reduce the risks of infection and relapse after 
stringently TCD alternative donor transplantation. 
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The spectrum of Aspergillus induced human pulmonary 
afflictions vary greatly from apparently harmless 
colonization to a fulminant and rapidly fatal disease. 
Invasive aspergillosis (IA) is a disease that occurs 
primarily in severely immunocompromised patients, 
clinical diagnosis in whom is often difficult and missed, 
adding to the severity of the outcome. 
Aims and objectives: To study the occurrence of IA 
in cases of chronic bronchopulmonary disorders with 
locally and/ or systemically immunocompromised con- 
ditions and correlate the role of clinical and radiological 
parameters of these patients with a battery of laboratory 
investigations in the early diagnosis and management. 
Materials and methods: Thirty-four patients of chronic 
bronchopulmonary disorders with suspected aspergillosis 
and underlying immunocompromised state were studied. 
Thorough clinical, hematological and radiological exam- 
inations were carried out. Sputum, bronchial aspirate/ 
BAL and serum samples were collected. Microscopy and 
culture for Aspergillus spp in addition to detection of 
specific anti-A. fumigatus IgG and IgE by ELISA and 
skin sensitivity tests against Aspergillus spp were per- 
formed. 
Results: Out of 34 cases studied, 7 were diagnosed as IA: 
2 as highly probable and 5 as probable cases. IA was 
found to be most common in ~20 and ~60 years of age 
